1GlintborgD, Andersen M. An update on the pathogenesis, in-flammation,and metabolism in hirsutism and polycystic ovary syn-drome[J].Gynecol endocrinol, 2010,26(4):281-296.
8HickeyJ,Tanasijevic B, Barry ER, etal. Epigenetic regulator^mechanisms during preimplantation development [J]. Birth DefectsRes C Embryo Today, 2009,87(4):297-313.
10JiangB, Kenna HA, Rasgon NL. Genetic overlap between poly-cysti c ovary syndrome and bipolar disorder: The endophenotype hy-pothesis [J]. Med Hypotheses,2009,73(6):996-1004.
5Barber TM, McCarthy MI, Franks S, et al. Metabolic syndrome in polycystic ovary syndrome [J]. Endokrynol Pol,2007,58(1): 34-41.
6Stanley T, Misra M. Polycystic ovary syndrome in obese adolescents [J]. Curr Opin Endocrinol Diabetes Obes,2008,15( 1 ):30--36.
7Celik O, Yesilada E, Hascalik S, et al. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS[J]. Reprod Biomed Online,2010,20(4):492-498.
8Seow KM, Juan CC, Hsu Y, et al. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor sustrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery[J]. Hum Reprod, 2007,22(4) : 1003-1010.
9Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women [J]. J Endocrinol, 2007,192( 3 ) : 585-594.
10Kowalska I, Straezkowski M, Nikolajuk A, et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome[J]. Hum Reprod, 2007,22 (7) : 1824-1829.
